» Articles » PMID: 29563165

Risk Factors for Endometritis and Incident Infection: a Secondary Data Analysis of the T Cell Response Against Chlamydia (TRAC) Study

Overview
Date 2018 Mar 23
PMID 29563165
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Assess risk factors for incident and endometrial infection and determine if is associated with histological endometritis, an indicator of pelvic inflammatory disease.

Methods: This study was a secondary data analysis within the T cell Response Against Chlamydia (TRAC) Study, a prospective evaluation of 246 women with or at risk for from urban outpatient clinics, who were followed quarterly for 12 months. Risk factors for incident infection were determined by Cox regression. Relative risks were estimated by Poisson regression with robust error measurements for models examining the association between and endometritis (histological evidence of plasma cells in endometrial stroma and neutrophils in the endometrial epithelium) and for models examining risk factors for detection of endometrial infection.

Results: prevalence was 16.7%, incidence was 25.3 per 100 person-years and 23% had repeated positive tests. Black race (non-black HR 0.4, 95% CI 0.2 to 0.9), less education (HR 2.4, 95% CI 1.2 to 5.1) and a new sexual partner (HR 3.1, 95% CI 1.7 to 5.4) were associated with incident was associated with endometritis (RR 2.0, 95% CI 1.1 to 3.7). (RR 2.0, 95% CI 1.2 to 3.4) and endometrial (RR 1.7, 95% CI 1.1 to 2.8) were associated with endometrial .

Conclusions: is prevalent in women at high risk for , persists over multiple follow-up visits and is associated with histological endometritis. Studies are needed to determine if screening for will improve reproductive outcomes.

Citing Articles

Diagnostic-avoiding Chlamydia trachomatis variants detected in cervical and endometrial specimens from women during 16S microbiome profiling.

Jeong S, Tollison T, Brochu H, Chou H, Yu T, Baghaie P BMC Infect Dis. 2025; 25(1):349.

PMID: 40075274 PMC: 11905726. DOI: 10.1186/s12879-025-10689-w.


Defining a panel of principal bacteria associated with endometritis.

Ferreira D, Ferrari M, Morais D, Santos R, Costa M, Mota K JBRA Assist Reprod. 2024; 29(1):150-159.

PMID: 39688441 PMC: 11867259. DOI: 10.5935/1518-0557.20240088.


Development and validation of a predictive model for postpartum endometritis.

Wang X, Shao H, Liu X, Feng L PLoS One. 2024; 19(7):e0307542.

PMID: 39042620 PMC: 11265687. DOI: 10.1371/journal.pone.0307542.


infection in the female reproductive system: Diseases and treatment.

Yu J, Zhou Y, Luo H, Su X, Gan T, Wang J Front Microbiol. 2023; 14:1098276.

PMID: 36896431 PMC: 9989269. DOI: 10.3389/fmicb.2023.1098276.


Latest Advances in Laboratory Detection of Mycoplasma genitalium.

Waites K, Crabb D, Ratliff A, Geisler W, Atkinson T, Xiao L J Clin Microbiol. 2023; 61(3):e0079021.

PMID: 36598247 PMC: 10035321. DOI: 10.1128/jcm.00790-21.


References
1.
Zou G . A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004; 159(7):702-6. DOI: 10.1093/aje/kwh090. View

2.
Andersen B, Sokolowski I, Ostergaard L, Moller J, Olesen F, Jensen J . Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect. 2006; 83(3):237-41. PMC: 2659104. DOI: 10.1136/sti.2006.022970. View

3.
Manhart L, Holmes K, Hughes J, Houston L, Totten P . Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health. 2007; 97(6):1118-25. PMC: 1874220. DOI: 10.2105/AJPH.2005.074062. View

4.
Jurstrand M, Jensen J, Magnuson A, Kamwendo F, Fredlund H . A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy. Sex Transm Infect. 2007; 83(4):319-23. PMC: 2598688. DOI: 10.1136/sti.2007.024752. View

5.
Haggerty C, Totten P, Astete S, Lee S, Hoferka S, Kelsey S . Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect. 2008; 84(5):338-42. PMC: 2572206. DOI: 10.1136/sti.2008.030486. View